Table III.
Baseline clinical characteristics of pancreatic cancer patients.
| GI hemorrhage | ||
|---|---|---|
| Variables | Presence, n (%) | P-value |
| Gender, male/female | 24 (12.6)/8 (14.3) | NS |
| Age, yearsa | ||
| ≤65 | 22 (12.4) | NS |
| >65 | 10 (14.7) | |
| Alcohol, yes/no | 29 (17.4)/3 (3.8) | <0.01 |
| Smoking, yes/no | 25 (17.9)/7 (6.6) | <0.01 |
| Past hemorrhage history, yes/no | 2 (66.7)/30 (12.3) | <0.01 |
| Past ulcer history, yes/no | 3 (13.6)/29 (12.9) | NS |
| Past diabetes history, yes/no | 4 (16.0)/28 (12.7) | NS |
| Past cirrhosis history, yes/no | 2 (6.7)/30 (13.9) | NS |
| Initial stage, I/II/III/IV | 8 (11.9)/4 (66.7)/6 (20.7)/14 (9.7) | <0.01 |
| Recived treatment prior to hemorrhage, chemotherapy/concurrent chemoradiotherapy/others | 18 (11.5)/8 (13.3)/6 (20.0) | NS |
| Tumor location, head of pancreas/body of pancreas/tail of panaceas | 13 (9.2)/13 (26.5)/6 (10.9) | <0.01 |
| Initial clinical symptoms, stained yellow/abdominal distension or pain/diabete/ileus/others | 12 (18.8)/18 (13.6)/0 (0)/1 (7.7)/1 (4.2) | NS |
| CA19-9 at diagnosis, U/ml | ||
| ≤1,000 | 13 (7.6) | <0.01 |
| >1,000 | 19 (25.3) | |
| Initial blood pressure | ||
| Systolic, mmHga | 131.6±39.0 | NS |
| Diastolic, mmHga | 76.0±17.5 | NS |
| Initial heart ratesa | 93.0±26.5 | NS |
| Hemoglobin, g/dla | 8.4±17.1 | NS |
| Platelet, 109/la | 208±147 | NS |
| INR/PTT, seca | 1.13±0.36/45.1±54.7 | NS |
a
Mean ± standard deviation. NS, not significant; INR, international normalized ratio; PTT, partial thromboplastin time; Hb, hemoglobin; GI, gastrointestinal; CA19-9, carbohydrate antigen 19-9. GI, gastrointestinal.